# LL2-07 digest — Ch7 Tobacco industry manipulation of research

EEA Report No 1/2013, report pp. 151–178 (PDF 153–180).

- **Author:** Lisa A. Bero, sole author.
- **Panel 7.1** (pp. 164–165): Smith, Gilmore and Fooks. Complementary, not a dissent.
- **Box 7.2:** quotes the WHO Committee of Experts on Tobacco Industry Documents (2000).
- **Table 7.2:** EEA-compiled.
- No industry response panel.

## Core argument
The chapter is not a conventional "early warning" case. It maps how an industry manipulated the production, synthesis and use of evidence on second-hand smoke (SHS) to delay regulation. The main sources are internal documents released through US litigation, together with the author's own meta-research.

- **Aim:** the industry's "primary motivation… has been to generate controversy" (p. 152).
- **Engine:** "Policymaking is facilitated by consensus" while science "is characterised by uncertainty" (p. 153). Controversy "is likely to slow or prevent regulation" (p. 154).
- **Intent in the documents:** research was the "antidote" to the passive-smoking issue (1978), and teams would "keep the controversy alive" (1988) (p. 154).
- **Constancy and control:** the strategies were constant from the 1950s to the 1990s, and were controlled by lawyers and executives, "rather than scientists" (p. 152).

## Key evidence
- **Eight strategies (Box 7.1, p. 155):** fund, hide, publish, suppress, criticise, change standards, press, policymakers.
- **Funding bodies:**
  - The Council for Tobacco Research was set up for PR; lawyers controlled its funding from 1966 (p. 156).
  - 70% of the Center for Indoor Air Research's "peer-reviewed" projects examined non-tobacco pollutants; almost two-thirds of its executive-reviewed "special" projects concerned SHS, mostly exposure. A Congressional subcommittee found that one ventilation study it funded had "altered and fabricated" data (pp. 156–157).
  - It was reinvented in 2000 (p. 157).
- **Hidden sponsorship (p. 158):** sidestream-toxicity findings kept unpublished; a lab coordinator found by a University of Geneva commission to be a "sponsored agent"; a lawyer-managed study that, per an original investigator's reanalysis, excluded inconvenient data, with the full data changing its conclusion ten years later.
- **Reviews:** among 106 reviews, **industry affiliation (labelled "sponsored" in the table) was the only predictor of concluding SHS "not harmful" (OR 88.4, 95% CI 16.4–476.5)**. Quality and peer review did not predict, contrary to the authors' own a priori hypotheses (Table 7.1, p. 161). None of 11 symposia was peer reviewed (p. 159).
- **Standards (pp. 162–163):**
  - The industry shaped tar-yield (ISO) and ventilation "comfort" (ASHRAE) standards.
  - "Sound science" campaigns promoted "unreasonably high standards of proof".
  - US data-access and data-quality laws, pushed by the industry while hiding its role, apply only to publicly funded data (per the chapter).
- **Panel 7.1:** a proposed rule to discount relative risks below 2.0 (no EU resolution adopted, p. 164); BAT considered lobbying for "structured risk assessment" to "remove the possibility" of smoking restrictions; a front-group "Risk Forum" that "contributed to" EU Treaty "burden" language. Success "not yet possible to assess" (p. 165).
- **Press and policy:** 66% of newspaper articles conveyed "continuing controversy" (p. 166). In the 1992 EPA risk assessment, 64% of submissions called it invalid, 71% of those industry-linked. The volume "probably" delayed release (p. 153; "considerably delayed", p. 166), though some criticisms were "valid" (p. 153).

## Authors' lessons and recommendations
- **Lessons:** sponsorship is associated with favourable conclusions without visibly poorer methods; the reasons "are not clear", but bias "may be" introduced through question framing, conduct and non-publication (pp. 167–168). Other sectors' methods are said to be similar (pp. 152, 167), yet the author also says the field "must learn more" before concluding so (p. 168).
- **Recommendations:**
  - five questions to trace the source of a controversy (p. 167);
  - full disclosure of sponsors' roles and personal financial ties in papers, the press and testimony;
  - independent peer review (p. 169);
  - disclosure is "necessary, but not sufficient";
  - bans on tobacco-industry research funding "warranted" (pp. 169–170).

## Mechanisms
- Doubt as product, delay as goal.
- Control of the research pipeline end to end.
- Legal privilege shielding knowledge.
- Laundered credibility.
- Distraction through alternative causes.
- Technical fixes offered instead of restricting the hazard.
- Raising the proof standard and removing regulators' discretion (anti-precautionary by design).
- Asymmetric transparency.
- Flooding participatory processes.
- Reinventing vehicles once exposed.

## Transferable insights
1. Where revenue depends on non-regulation, sustaining uncertainty can be deliberate and aimed at delay (pp. 153–156). **Strong** (internal documents).
2. Sponsorship is associated with conclusions without detectable method flaws (pp. 154, 160–161). **Strong** for the association, later corroborated; **suggestive** for the mechanism (reasons "not clear", p. 167).
3. Peer-review status did not predict conclusions; affiliation did (p. 161). **Moderate**.
4. Controlling which questions get funded matters as much as controlling results (pp. 155–157). **Moderate–strong**.
5. Legal structures hide knowledge. Forced disclosure is the main window, which creates observability bias (pp. 152, 155–156, 169). **Strong**.
6. Beyond attacking studies, an interested party may try to change evidentiary and procedural rules (pp. 162–165). **Strong** on intent; **mixed** on effect (US data laws enacted; EU RR < 2 rule not adopted; EU success "not yet possible to assess").
7. Transparency can be applied asymmetrically and used as a weapon (p. 163). **Moderate**.
8. Procedural safeguards favour the well-resourced (pp. 153, 166). **Strong** for these cases.
9. Measurement and design standards are quiet battlegrounds (pp. 157, 161–162). **Moderate**.
10. News practice can sustain apparent controversy after consensus forms (p. 166). **Moderate**.
11. Influence toolkits are portable and reinvented (pp. 154, 157, 164–165). **Strong** within tobacco.
12. Disclosure is insufficient; structural separation may be needed (pp. 169–170). **Asserted/moderate**.

## Caveats
- The chapter is largely a synthesis of the author's own work, updated lightly from 2005. It omits the WHO tobacco treaty (2003), the 2004 IARC classification, and the 2006 US court judgment.
- It does not quantify harm or date effective action.
- It reports the IARC 16% and 17% increases without noting that both confidence intervals include 1.
- It overstates "90 times more likely to be funded" (an odds ratio of affiliation, very wide CI). Calling the industry's publication-bias argument "invalid" is fair against its literal claim but understates the two-year time-lag bias the chapter itself reports.
- Internal inconsistencies: EPA delay "probably" (p. 153) vs "considerably" (p. 166); other industries' tactics asserted as "similar" (pp. 152, 167) yet said to need more study (p. 168). Cross-industry evidence rests partly on a single advocacy report (climate) and a mis-matched citation (asbestos).
- Panel 7.1 does not show that risk assessment is bad policy in itself.
- Table 7.2 has transcription errors.
- It concedes both sides "construct" evidence but examines only industry.
- Hindsight bias is limited, because the core evidence is contemporaneous internal intent.